Date | Form | Description | XBRL | Pages | |
---|---|---|---|---|---|
04/16/13 | 10-K | Annual report pursuant to Section 13 and 15(d) | 37 | ||
04/10/12 | 10-K | Annual report pursuant to Section 13 and 15(d) | 42 |
CV Sciences operates two distinct divisions: pharmaceuticals and consumer products. These divisions are supported by our medical and scientific advisory board, and state‐of‐the art production facilities.
Date | Form | Description | XBRL | Pages | |
---|---|---|---|---|---|
04/16/13 | 10-K | Annual report pursuant to Section 13 and 15(d) | 37 | ||
04/10/12 | 10-K | Annual report pursuant to Section 13 and 15(d) | 42 |